• Vertex Pharmaceuticals EPS for the quarter ending March 31, 2025 was $2.49, a 40.86% decline year-over-year.
• Vertex Pharmaceuticals 2024 annual EPS was $-2.08, a 114.97% decline from 2023.
• Vertex Pharmaceuticals 2023 annual EPS was $13.89, a 8.35% increase from 2022.
• Vertex Pharmaceuticals 2022 annual EPS was $12.82, a 42.29% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.